Impact Biomedical (IBO) Non Operating Interest Expenses (2022 - 2025)
Impact Biomedical (IBO) recorded Non Operating Interest Expenses of -$1.59 million in Q4 2025, compared with $270,000 a year earlier.
Powered by 
Analysis
Impact Biomedical (IBO) Non Operating Interest Expenses (2022 - 2025) Analysis & Trends
For FY2025, Impact Biomedical reported Non Operating Interest Expenses of -$793,000.
- Across earlier years, Non Operating Interest Expenses came in at $1.07 million in FY2024 (+139.9%), $444,000 in FY2023 (-3.9%) and $462,000 in FY2022.
- The Q4 2025 figure is the lowest quarterly Non Operating Interest Expenses in data going back to Q2 2022.
- On a year-over-year basis, Non Operating Interest Expenses rose in five of the last seven quarters, with growth averaging 81.6%.
- Peak year-over-year performance for Non Operating Interest Expenses in the last five years was growth of 199.0% in Q3 2024, against a decline of 16.5% in Q2 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $262,000 (Q3 2025), $260,000 (Q2 2025) and $271,000 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 217.00 Mn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | - |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | -477.00 Mn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 653.00 Mn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 269.00 Mn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | - |
| 10 | Impact Biomedical | 43.92 Mn | 47.11 Mn | 15,000.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -1.59 Mn |
| Sep 30, 2025 | 262,000.00 |
| Jun 30, 2025 | 260,000.00 |
| Mar 31, 2025 | 271,000.00 |
| Dec 31, 2024 | 270,000.00 |
| Sep 30, 2024 | 305,000.00 |
| Jun 30, 2024 | 261,000.00 |
| Mar 31, 2024 | 230,000.00 |
| Dec 31, 2023 | 125,000.00 |
| Sep 30, 2023 | 102,000.00 |
| Jun 30, 2023 | 116,000.00 |
| Mar 31, 2023 | 101,000.00 |
| Dec 31, 2022 | 99,000.00 |
| Sep 30, 2022 | 92,000.00 |
| Jun 30, 2022 | 139,000.00 |
API Access
Impact Biomedical Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "IBO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=IBO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();